Status: current, Defined. Date: 30-Apr 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3293441000168111 | Flecainide (Apo) (flecainide acetate 50 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3293451000168113 | Flecainide (Apo) 50 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Flecainide (Apo) 50 mg tablet | Is a | Flecainide (Apo) | true | Inferred relationship | Some | ||
| Flecainide (Apo) 50 mg tablet | Is a | flecainide acetate 50 mg tablet | true | Inferred relationship | Some | ||
| Flecainide (Apo) 50 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Flecainide (Apo) 50 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Flecainide (Apo) 50 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 911611180 | |
| Flecainide (Apo) 50 mg tablet | has Australian BoSS | flecainide acetate | true | Inferred relationship | Some | 911611179 | |
| Flecainide (Apo) 50 mg tablet | has intended active ingredient | flecainide | true | Inferred relationship | Some | 911611179 |
Reference Sets
Trade product unit of use reference set
FHIR